Showing results (41-50 of 307) with videos related to
Sort By:
Pageof 31
Clinical Parkinsonism & Related Disorders|August 29, 2022
Should "on-demand" treatments for Parkinson's disease OFF episodes be used earlier?Stuart H Isaacson, Fernando L Pagan, Mark F Lew, et al.The Lancet. Neurology|January 22, 2019
Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trialPeter A LeWitt, Robert A Hauser, Rajesh Pahwa, et al.Expert Opinion on Pharmacotherapy|March 23, 2007
Duodenal levodopa infusion for the treatment of Parkinson's diseaseJohan Samanta, Robert A HauserParkinsonism & Related Disorders|July 30, 2023
Importance of time to ON versus wearing OFF in total daily OFF time experienced by patients with Parkinson's diseaseStuart H Isaacson, Daniel Kremens, Yasar Torres-Yaghi, et al.Movement Disorders : Official Journal of the Movement Disorder Society|March 26, 2011
Determination of minimal clinically important change in early and advanced Parkinson's diseaseRobert A Hauser, Peggy Auinger, Journal of the Neurological Sciences|February 17, 2018
Tardive dyskinesia: Out of the shadowsRobert A Hauser, Daniel TruongExpert Review of Neurotherapeutics|July 25, 2024
Current use of neurotoxins for alleviating symptoms of cervical dystoniaStephen Aradi, Robert A HauserExpert Review of Medical Devices|October 25, 2023
Clinical benefit of transcutaneous afferent patterned stimulation (TAPS) in essential tremor patients with high unmet need: a secondary analysis of TAPS studiesStuart H Isaacson, Rajesh Pahwa, Salima Brillman, et al.Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|March 18, 2011
[123I]FP-CIT (DaTscan) SPECT brain imaging in patients with suspected parkinsonian syndromesRobert A Hauser, Donald G GrossetDrugs & Aging|June 25, 2005
Adenosine A2A receptor antagonists for Parkinson's disease: rationale, therapeutic potential and clinical experienceRobert A Hauser, Michael A SchwarzschildPageof 31